Humana Inc. $HUM Stake Increased by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC increased its stake in Humana Inc. (NYSE:HUM) by 97.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,560 shares of the insurance provider’s stock after buying an additional 1,261 shares during the period. Chicago Partners Investment Group LLC’s holdings in Humana were worth $607,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Humana in the second quarter worth $28,164,000. Mutual of America Capital Management LLC increased its stake in Humana by 8.6% during the second quarter. Mutual of America Capital Management LLC now owns 23,206 shares of the insurance provider’s stock valued at $5,673,000 after purchasing an additional 1,844 shares during the last quarter. Chevy Chase Trust Holdings LLC increased its stake in Humana by 0.7% during the second quarter. Chevy Chase Trust Holdings LLC now owns 64,556 shares of the insurance provider’s stock valued at $15,783,000 after purchasing an additional 479 shares during the last quarter. Nordea Investment Management AB increased its stake in Humana by 5.2% during the second quarter. Nordea Investment Management AB now owns 10,222 shares of the insurance provider’s stock valued at $2,475,000 after purchasing an additional 507 shares during the last quarter. Finally, Ritholtz Wealth Management bought a new stake in Humana during the second quarter valued at $538,000. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

HUM stock opened at $295.20 on Wednesday. The company has a market capitalization of $35.50 billion, a P/E ratio of 22.66, a PEG ratio of 1.66 and a beta of 0.42. The company has a 50-day simple moving average of $281.27 and a 200 day simple moving average of $258.60. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company earned $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Friday, September 26th. Humana’s dividend payout ratio is presently 27.17%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent research reports. Sanford C. Bernstein boosted their target price on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Barclays lowered their target price on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research note on Friday, October 3rd. Truist Financial set a $300.00 target price on shares of Humana in a research note on Tuesday, October 14th. The Goldman Sachs Group initiated coverage on shares of Humana in a research note on Tuesday, October 14th. They set a “sell” rating and a $235.00 target price for the company. Finally, Wall Street Zen lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Eight research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $297.58.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.